<p>梅萨实验室（NASDAQ:MLAB - 获取免费报告）在周三发布的一份报告中被 StockNews.com 的股票研究分析师从 “买入” 评级下调至 “持有” 评级。</p>
<p>获取 <strong>梅萨实验室</strong> 的提醒：</p>
<p>其他几家券商也对 MLAB 发表了评论。富国银行在 8 月 27 日的报告中开始覆盖梅萨实验室的股票。他们给予该公司的评级为 “减持”，目标价为 120.00 美元。Evercore ISI 在 10 月 1 日的研究报告中将梅萨实验室的目标价从 120.00 美元上调至 160.00 美元，并给予该公司 “跑赢大盘” 的评级。</p>
<p><strong>获取我们对梅萨实验室的最新分析</strong></p>
<h2>梅萨实验室股票下跌 5.5%</h2>
<p>周三，NASDAQ MLAB 的股票开盘价为 112.40 美元。该公司的 50 日简单移动平均线为 124.09 美元，200 日简单移动平均线为 115.00 美元。梅萨实验室的 12 个月低点为 82.86 美元，12 个月高点为 141.17 美元。该公司的流动比率为 1.94，速动比率为 1.37，债务与股本比率为 1.38。该公司的市值为 6.0808 亿美元，市盈率为-2.47，贝塔值为 0.87。</p>
<h2>梅萨实验室的内部买卖</h2>
<p>在其他新闻中，首席执行官 Gary M. Owens 在 10 月 28 日星期一出售了 2,518 股公司的股票，交易价格为 113.62 美元，总价值为 286,095.16 美元。出售后，首席执行官现在直接拥有 45,888 股公司的股票，价值为 5,213,794.56 美元。此次交易使其持股量减少了 0.00%。该交易在向 SEC 提交的文件中披露，文件可通过 SEC 网站获取。在其他新闻中，高级副总裁 Brian David Archbold 在 9 月 13 日星期五出售了 1,499 股梅萨实验室的股票，交易价格为 125.00 美元，总价值为 187,375.00 美元。该交易在向证券交易委员会提交的文件中披露，文件可通过此链接获取。此外，首席执行官 Gary M. Owens 在 10 月 28 日星期一再次出售了 2,518 股股票，交易价格为 113.62 美元，总交易额为 286,095.16 美元。出售后，首席执行官现在直接拥有 45,888 股公司的股票，价值为 5,213,794.56 美元。此次交易使其持股量减少了 0.00%。该出售的披露信息可以在这里找到。内部人士持有公司 4.40% 的股票。</p>
<h2>机构资金流入和流出</h2>
<p>对冲基金和其他机构投资者最近对该公司的持仓进行了调整。Meros Investment Management LP 在第二季度购买了梅萨实验室的新头寸，价值约为 2,456,000 美元。Keeley Teton Advisors LLC 在第一季度购买了梅萨实验室的新股份，价值为 2,606,000 美元。Charles Schwab Investment Management Inc.在第三季度将其在梅萨实验室的股份提高了 38.6%。Charles Schwab Investment Management Inc.现在拥有 62,609 股医疗仪器供应商的股票，价值为 8,130,000 美元，此前在上个季度购买了额外的 17,450 股。Eagle Asset Management Inc.在第三季度将其在梅萨实验室的持股提高了 10.9%。Eagle Asset Management Inc.现在拥有 165,955 股医疗仪器供应商的股票，价值为 19,722,000 美元，此前在上个季度购买了额外的 16,293 股。最后，Dimensional Fund Advisors LP 在第二季度将其在梅萨实验室的持仓提高了 7.1%。Dimensional Fund Advisors LP 现在拥有 131,891 股医疗仪器供应商的股票，价值为 11,444,000 美元，此前在上个季度购买了额外的 8,722 股。机构投资者持有公司 90.60% 的股票。</p>
<h2>梅萨实验室公司简介</h2>
<p>（获取免费报告）</p>
<p>梅萨实验室公司在北美、欧洲、亚太地区及国际上开发、设计、制造、销售和服务生命科学工具及质量控制产品和服务。灭菌和消毒控制部门提供生物、化学和清洁指示剂，用于评估制药、医疗器械和医疗行业中灭菌、消毒和清洁过程的有效性。</p>
<h2>特色文章</h2>
<ul>
<li>五只我们更看好的股票，胜过梅萨实验室</li>
<li>现在值得购买的三只最佳金融科技股票</li>
<li>家得宝股票：2024 年目标 12%，2025 年再增 25%</li>
<li>宝洁公司 NYSE: PG 在不稳定的指导后回落</li>
<li>特斯拉的估值是泡沫还是有实际增长支撑？</li>
<li>能源和石油股票解析</li>
<li>上周运输股票领跑：它们能否继续上涨？</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<p>→ 现在市场上最值得关注的 “沉睡巨人” 加密货币（来自 Crypto 101 Media）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMzNQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMzNQ"/></p>
<h2>你现在应该投资 1,000 美元在梅萨实验室吗？</h2>
<p>在考虑梅萨实验室之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而梅萨实验室并不在名单上。</p>
<p>虽然梅萨实验室目前在分析师中获得了 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

MLAB

<p>StockNews.com 已将 Mesa Laboratories（NASDAQ:MLAB）的评级从 “买入” 下调至 “持有”。该股票开盘价为 40.40 美元，下跌 5.5%。其他券商也发表了评论，富国银行给予 “减持” 评级，而 Evercore ISI 则上调了其目标价。内部交易方面，首席执行官 Gary M. Owens 出售了部分股份，减少了其持股比例。机构投资者持有该公司 90.60% 的股份，近期有多个基金进行了购买。Mesa Laboratories 专注于生命科学工具和质量控制产品</p>

<p>Mesa Laboratories (NASDAQ:MLAB - Get Free Report) was downgraded by equities research analysts at StockNews.com from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report released on Wednesday.</p>
<div class="lb-trans"><p>梅萨实验室（NASDAQ:MLAB - 获取免费报告）在周三发布的一份报告中被 StockNews.com 的股票研究分析师从 “买入” 评级下调至 “持有” 评级。</p>
</div><p>Get <strong>Mesa Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>梅萨实验室</strong> 的提醒：</p>
</div><p>Several other brokerages have also commented on MLAB. Wells Fargo &amp; Company started coverage on shares of Mesa Laboratories in a report on Tuesday, August 27th. They issued an &#34;underweight&#34; rating and a $120.00 price objective for the company. Evercore ISI lifted their price target on Mesa Laboratories from $120.00 to $160.00 and gave the company an &#34;outperform&#34; rating in a research report on Tuesday, October 1st.</p>
<div class="lb-trans"><p>其他几家券商也对 MLAB 发表了评论。富国银行在 8 月 27 日的报告中开始覆盖梅萨实验室的股票。他们给予该公司的评级为 “减持”，目标价为 120.00 美元。Evercore ISI 在 10 月 1 日的研究报告中将梅萨实验室的目标价从 120.00 美元上调至 160.00 美元，并给予该公司 “跑赢大盘” 的评级。</p>
</div><p><strong>Get Our Latest Analysis on Mesa Laboratories</strong></p>
<div class="lb-trans"><p><strong>获取我们对梅萨实验室的最新分析</strong></p>
</div><h2>Mesa Laboratories Stock Down 5.5 %</h2>
<div class="lb-trans"><h2>梅萨实验室股票下跌 5.5%</h2>
</div><p>Shares of NASDAQ MLAB opened at $112.40 on Wednesday. The firm has a fifty day simple moving average of $124.09 and a two-hundred day simple moving average of $115.00. Mesa Laboratories has a 12 month low of $82.86 and a 12 month high of $141.17. The company has a current ratio of 1.94, a quick ratio of 1.37 and a debt-to-equity ratio of 1.38. The firm has a market capitalization of $608.08 million, a PE ratio of -2.47 and a beta of 0.87.</p>
<div class="lb-trans"><p>周三，NASDAQ MLAB 的股票开盘价为 112.40 美元。该公司的 50 日简单移动平均线为 124.09 美元，200 日简单移动平均线为 115.00 美元。梅萨实验室的 12 个月低点为 82.86 美元，12 个月高点为 141.17 美元。该公司的流动比率为 1.94，速动比率为 1.37，债务与股本比率为 1.38。该公司的市值为 6.0808 亿美元，市盈率为-2.47，贝塔值为 0.87。</p>
</div><h2>Insider Buying and Selling at Mesa Laboratories</h2>
<div class="lb-trans"><h2>梅萨实验室的内部买卖</h2>
</div><p>In other news, CEO Gary M. Owens sold 2,518 shares of the business's stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $113.62, for a total value of $286,095.16. Following the sale, the chief executive officer now directly owns 45,888 shares of the company's stock, valued at $5,213,794.56. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, SVP Brian David Archbold sold 1,499 shares of Mesa Laboratories stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $125.00, for a total value of $187,375.00. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. Also, CEO Gary M. Owens sold 2,518 shares of the stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $113.62, for a total transaction of $286,095.16. Following the sale, the chief executive officer now directly owns 45,888 shares in the company, valued at $5,213,794.56. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.40% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，首席执行官 Gary M. Owens 在 10 月 28 日星期一出售了 2,518 股公司的股票，交易价格为 113.62 美元，总价值为 286,095.16 美元。出售后，首席执行官现在直接拥有 45,888 股公司的股票，价值为 5,213,794.56 美元。此次交易使其持股量减少了 0.00%。该交易在向 SEC 提交的文件中披露，文件可通过 SEC 网站获取。在其他新闻中，高级副总裁 Brian David Archbold 在 9 月 13 日星期五出售了 1,499 股梅萨实验室的股票，交易价格为 125.00 美元，总价值为 187,375.00 美元。该交易在向证券交易委员会提交的文件中披露，文件可通过此链接获取。此外，首席执行官 Gary M. Owens 在 10 月 28 日星期一再次出售了 2,518 股股票，交易价格为 113.62 美元，总交易额为 286,095.16 美元。出售后，首席执行官现在直接拥有 45,888 股公司的股票，价值为 5,213,794.56 美元。此次交易使其持股量减少了 0.00%。该出售的披露信息可以在这里找到。内部人士持有公司 4.40% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the company. Meros Investment Management LP purchased a new position in Mesa Laboratories in the 2nd quarter worth approximately $2,456,000. Keeley Teton Advisors LLC bought a new stake in shares of Mesa Laboratories in the 1st quarter worth $2,606,000. Charles Schwab Investment Management Inc. raised its stake in shares of Mesa Laboratories by 38.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 62,609 shares of the medical instruments supplier's stock worth $8,130,000 after purchasing an additional 17,450 shares during the last quarter. Eagle Asset Management Inc. lifted its holdings in shares of Mesa Laboratories by 10.9% during the third quarter. Eagle Asset Management Inc. now owns 165,955 shares of the medical instruments supplier's stock valued at $19,722,000 after purchasing an additional 16,293 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Mesa Laboratories by 7.1% during the second quarter. Dimensional Fund Advisors LP now owns 131,891 shares of the medical instruments supplier's stock valued at $11,444,000 after buying an additional 8,722 shares during the last quarter. Institutional investors own 90.60% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近对该公司的持仓进行了调整。Meros Investment Management LP 在第二季度购买了梅萨实验室的新头寸，价值约为 2,456,000 美元。Keeley Teton Advisors LLC 在第一季度购买了梅萨实验室的新股份，价值为 2,606,000 美元。Charles Schwab Investment Management Inc.在第三季度将其在梅萨实验室的股份提高了 38.6%。Charles Schwab Investment Management Inc.现在拥有 62,609 股医疗仪器供应商的股票，价值为 8,130,000 美元，此前在上个季度购买了额外的 17,450 股。Eagle Asset Management Inc.在第三季度将其在梅萨实验室的持股提高了 10.9%。Eagle Asset Management Inc.现在拥有 165,955 股医疗仪器供应商的股票，价值为 19,722,000 美元，此前在上个季度购买了额外的 16,293 股。最后，Dimensional Fund Advisors LP 在第二季度将其在梅萨实验室的持仓提高了 7.1%。Dimensional Fund Advisors LP 现在拥有 131,891 股医疗仪器供应商的股票，价值为 11,444,000 美元，此前在上个季度购买了额外的 8,722 股。机构投资者持有公司 90.60% 的股票。</p>
</div><h2>Mesa Laboratories Company Profile</h2>
<div class="lb-trans"><h2>梅萨实验室公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.</p>
<div class="lb-trans"><p>梅萨实验室公司在北美、欧洲、亚太地区及国际上开发、设计、制造、销售和服务生命科学工具及质量控制产品和服务。灭菌和消毒控制部门提供生物、化学和清洁指示剂，用于评估制药、医疗器械和医疗行业中灭菌、消毒和清洁过程的有效性。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Mesa Laboratories</li>
<li>The 3 Best Fintech Stocks to Buy Now</li>
<li>Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025</li>
<li>Procter &amp; Gamble NYSE: PG Pulls Back After Shaky Guidance</li>
<li>Is Tesla's Valuation a Bubble or Backed by Real Growth?</li>
<li>Energy and Oil Stocks Explained</li>
<li>Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过梅萨实验室</li>
<li>现在值得购买的三只最佳金融科技股票</li>
<li>家得宝股票：2024 年目标 12%，2025 年再增 25%</li>
<li>宝洁公司 NYSE: PG 在不稳定的指导后回落</li>
<li>特斯拉的估值是泡沫还是有实际增长支撑？</li>
<li>能源和石油股票解析</li>
<li>上周运输股票领跑：它们能否继续上涨？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><p>→ Top &#34;Sleeping Giant&#34; Crypto In The Market Now (From Crypto 101 Media)(Ad)</p>
<div class="lb-trans"><p>→ 现在市场上最值得关注的 “沉睡巨人” 加密货币（来自 Crypto 101 Media）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMzNQ" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10335&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Mesa Laboratories right now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在梅萨实验室吗？</h2>
</div><p>Before you consider Mesa Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑梅萨实验室之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而梅萨实验室并不在名单上。</p>
</div><p>While Mesa Laboratories currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然梅萨实验室目前在分析师中获得了 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Mesa Laboratories（纳斯达克股票代码：MLAB）的股票评级被 StockNews.com 下调